You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,411 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Terminated
  • Recurrent Neuroblastoma
  • Neuroblastoma
  • Fenretinide/LXS Oral Powder
  • +2 more
  • Chicago, Illinois
  • +3 more
2022-03-17
Mar 17, 2022
C
Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2021-07-26
Jul 26, 2021
U
Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
2021-11-17
Nov 17, 2021
F
Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
2022-02-10
Feb 10, 2022
N
Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
R
Withdrawn
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +7 more
  • Inotuzumab Ozogamicin
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2022-01-13
Jan 13, 2022
A
Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
2021-07-19
Jul 19, 2021
E
Recruiting
  • B Acute Lymphoblastic Leukemia
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • New Haven, Connecticut
  • +8 more
2021-03-04
Mar 4, 2021
M
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-11-12
Nov 12, 2020
B
Terminated
  • Kaposiform Hemangioendothelioma (KHE)
  • +2 more
  • Palo Alto, California
  • +6 more
2021-05-20
May 20, 2021
D
Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tampa, Florida
  • +2 more
2022-02-14
Feb 14, 2022
C
Completed
  • Intraocular Retinoblastoma
  • liposomal vincristine sulfate
  • +5 more
  • Arcadia, California
  • +10 more
2021-07-12
Jul 12, 2021
U
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Colchester, Essex, United Kingdom
  • +2 more
2021-10-20
Oct 20, 2021
H
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-08-15
Aug 15, 2021
U
Completed
  • Kidney Cancer
  • +5 more
  • glutamic acid
  • placebo
  • Fort Myers, Florida
  • +5 more
2021-07-22
Jul 22, 2021
S
Active, not recruiting
  • Retinoblastoma
  • Retinal Neoplasm
  • Enucleation
  • +9 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-01-10
Jan 10, 2022
U
Terminated
  • Peripheral Neuropathy
  • Limoges, France
    CHU Limoges
2021-11-12
Nov 12, 2021
S
Not yet recruiting
  • Primary Extranodal Lymphoma
  • DLBCL
  • (no location specified)
2022-04-06
Apr 6, 2022
M
Not yet recruiting
  • Solid Tumor
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
2022-03-29
Mar 29, 2022
N
Completed
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
2021-12-21
Dec 21, 2021
C
Recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • No Intervention, Observational Study
  • Washington, District of Columbia
    Children's National Health System
2021-10-04
Oct 4, 2021
H
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2022-01-22
Jan 22, 2022
T
Active, not recruiting
  • Retinoblastoma
  • filgrastim
  • +6 more
  • Vancouver, British Columbia, Canada
  • +5 more
2021-10-22
Oct 22, 2021